RP has experienced significant organic and partner-led expansion. Over the last six months, RP has expanded into Las Vegas, Nevada; Austin, Texas; Greensboro, North Carolina; and Atlanta, Georgia as well as the New Jersey/Pennsylvania market. In addition, RP has added 30 new client sites and has deepened its capabilities in radiology consulting, IT and revenue cycle management services. This latest additional financing follows the previously announced $234 million equity raise in March 2018 and $200 million equity raise in May 2017.
Barclays served as exclusive financial advisor and Goodwin Proctor as legal counsel to RP. TripleTree served as financial advisor and Kirkland & Ellis served as legal counsel to SIH.
About Radiology Partners
Radiology Partners is the largest physician-led and physician-owned radiology practice in the U.S., serving more than 1,000 hospitals and other healthcare facilities across the nation. As a physician-led practice, our mission is to transform radiology by innovating across clinical value, service and economics, while elevating the role of radiology and radiologists in healthcare. Using a proven healthcare services model, Radiology Partners provides consistent, high quality care to patients, while delivering enhanced value to the hospitals, clinics, imaging centers and referring physicians we serve.
About Starr Investment Holdings
Starr Investment Holdings, LLC ("SIH") is a multi-billion dollar New York and Nashville-based investment adviser that manages capital on behalf of the Starr Companies together with that of select institutions and family offices. SIH invests in privately-held technology-enabled services businesses with a particular focus on healthcare services. SIH partners with world-class management teams, supporting them with flexible long-term capital and strategic resources.
About NEA
New Enterprise Associates, Inc. (NEA) is a global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors and geographies. With more than $20 billion in cumulative committed capital since the firm’s first fund closed in 1978, NEA invests in technology and healthcare companies at all stages in a company’s lifecycle, from seed stage through IPO. The firm's long track record of successful investing includes more than 225 portfolio company IPOs and more than 375 acquisitions.
Back to HCB News
